Keyphrases
Integrative Analysis
100%
Pricing Method
100%
Six Dimensions
100%
Outcome-based Contracts
100%
Non-small Cell Lung Cancer (NSCLC)
33%
Monte Carlo Simulation
33%
EGFR mutation
33%
Price Estimation
33%
Outcome-based Pricing
33%
Osimertinib
33%
Reference Dependence
16%
Cost-effectiveness Analysis
16%
Concept Application
16%
Cost-utility Analysis
16%
Willingness to Pay
16%
Market Conditions
16%
Price Level
16%
Price Scenarios
16%
Pharmacology, Toxicology and Pharmaceutical Science
Epidermal Growth Factor Receptor
100%
Non Small Cell Lung Cancer
100%
Osimertinib
100%
Social Sciences
Pricing
100%
Contract Law
66%
Lung Cancer
22%
Cost-Effectiveness Analysis
11%
Willingness-to-Pay
11%
Price Level
11%
Cost-Utility Analysis
11%
Economics, Econometrics and Finance
Pricing
100%
Monte Carlo Simulation
22%
Willingness to Pay
11%
Cost-Effectiveness Analysis
11%
Price Level
11%